Intellia Therapeutics NTLA
NASDAQ NTLA
$11.64 -0.20 (-1.69%)
As of: Oct 21, 2026 · 3:59 PM EDT

Intellia Therapeutics (NTLA) EV to CFO (2016 - 2017)

Updated

Intellia Therapeutics' (NTLA) EV to CFO stood at 7.33 in Q1 2017.

Analysis

Intellia Therapeutics (NTLA) EV to CFO (2016 - 2017) Analysis & Trends

On a TTM basis, Intellia Therapeutics' EV to CFO came in at -18.00 as of Mar 31, 2017; for FY2016, it was 0.51.

  • Per Business Quant, the preceding three quarters came in at 0.51 (Q4 2016), 7.15 (Q3 2016) and 2.18 (Q2 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Intellia Therapeutics 1.57 Bn -208.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 7.33
Dec 31, 2016 0.51
Sep 30, 2016 7.15
Jun 30, 2016 2.18
API Access

Intellia Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=NTLA&period=max&api_key=YOUR_API_KEY